

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.05099273 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.87627640 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.87627640 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.82273639 |
| 5 | negative thymic T cell selection (GO:0045060) | 5.74568445 |
| 6 | negative T cell selection (GO:0043383) | 5.70995145 |
| 7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.14442811 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01755810 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.01755810 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.86467207 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69287516 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.67357727 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.65040484 |
| 14 | thymic T cell selection (GO:0045061) | 4.60493128 |
| 15 | regulation of T cell tolerance induction (GO:0002664) | 4.55360770 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.54865349 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.53831049 |
| 18 | T cell selection (GO:0045058) | 4.44278976 |
| 19 | interferon-gamma production (GO:0032609) | 4.40431243 |
| 20 | positive regulation of interleukin-2 production (GO:0032743) | 4.34019225 |
| 21 | response to interleukin-15 (GO:0070672) | 4.32285058 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.30590451 |
| 23 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.21876791 |
| 24 | growth hormone receptor signaling pathway (GO:0060396) | 4.17510341 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 4.16852635 |
| 26 | myeloid dendritic cell differentiation (GO:0043011) | 4.08105302 |
| 27 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.07130427 |
| 28 | myeloid dendritic cell activation (GO:0001773) | 4.06529361 |
| 29 | T cell migration (GO:0072678) | 4.04632272 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00833730 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99891245 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99891245 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.99891245 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99891245 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.99891245 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99891245 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98725709 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.97273647 |
| 39 | positive T cell selection (GO:0043368) | 3.90162904 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.87597052 |
| 41 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.86640383 |
| 42 | T cell costimulation (GO:0031295) | 3.82294051 |
| 43 | leukocyte aggregation (GO:0070486) | 3.81855668 |
| 44 | lymphocyte costimulation (GO:0031294) | 3.76874934 |
| 45 | activated T cell proliferation (GO:0050798) | 3.76481484 |
| 46 | tolerance induction (GO:0002507) | 3.72472870 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71879741 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70136272 |
| 49 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.70111928 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.60835637 |
| 51 | positive regulation of humoral immune response (GO:0002922) | 3.59149888 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.58633586 |
| 53 | cellular response to growth hormone stimulus (GO:0071378) | 3.57445047 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.57422429 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.56001187 |
| 56 | cellular extravasation (GO:0045123) | 3.55702671 |
| 57 | regulation of hypersensitivity (GO:0002883) | 3.55308769 |
| 58 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.52971872 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.49179948 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.47498031 |
| 61 | positive regulation of interleukin-12 production (GO:0032735) | 3.46063329 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45945999 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 3.44541996 |
| 64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.44117989 |
| 65 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.43890019 |
| 66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.42418113 |
| 67 | positive regulation of isotype switching (GO:0045830) | 3.41473954 |
| 68 | detection of other organism (GO:0098543) | 3.40700880 |
| 69 | natural killer cell activation (GO:0030101) | 3.36761733 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.35226948 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33132819 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.33031505 |
| 73 | response to type I interferon (GO:0034340) | 3.32216095 |
| 74 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.32043505 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 3.31808410 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 3.31478477 |
| 77 | T cell receptor signaling pathway (GO:0050852) | 3.31368942 |
| 78 | type I interferon signaling pathway (GO:0060337) | 3.30399692 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.30399692 |
| 80 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.28739401 |
| 81 | neutrophil activation (GO:0042119) | 3.28038694 |
| 82 | regulation of antigen processing and presentation (GO:0002577) | 3.27445270 |
| 83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26082980 |
| 84 | T-helper cell differentiation (GO:0042093) | 3.26042419 |
| 85 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.26042419 |
| 86 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.25667431 |
| 87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.24173093 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 3.24014027 |
| 89 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.22933265 |
| 90 | positive regulation of tolerance induction (GO:0002645) | 3.22750274 |
| 91 | detection of bacterium (GO:0016045) | 3.22574799 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.20748189 |
| 93 | regulation of regulatory T cell differentiation (GO:0045589) | 3.19824808 |
| 94 | dendritic cell differentiation (GO:0097028) | 3.19225481 |
| 95 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.16269590 |
| 96 | regulation of interleukin-2 production (GO:0032663) | 3.15891560 |
| 97 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14416787 |
| 98 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.12438095 |
| 99 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.11900861 |
| 100 | cytidine deamination (GO:0009972) | 3.10863880 |
| 101 | cytidine metabolic process (GO:0046087) | 3.10863880 |
| 102 | cytidine catabolic process (GO:0006216) | 3.10863880 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 3.10433748 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10411616 |
| 105 | response to peptidoglycan (GO:0032494) | 3.09932374 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 3.08820021 |
| 107 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.08196004 |
| 108 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.08196004 |
| 109 | lymphocyte migration (GO:0072676) | 3.07236301 |
| 110 | granulocyte activation (GO:0036230) | 3.07103004 |
| 111 | regulation of cell killing (GO:0031341) | 3.05431670 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02821351 |
| 113 | positive regulation of DNA recombination (GO:0045911) | 3.00739379 |
| 114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00737275 |
| 115 | regulation of T-helper cell differentiation (GO:0045622) | 3.00012460 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.99899155 |
| 117 | respiratory burst (GO:0045730) | 2.99323300 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.99211367 |
| 119 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.98972117 |
| 120 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.98972117 |
| 121 | regulation of alpha-beta T cell activation (GO:0046634) | 2.98724878 |
| 122 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.98144463 |
| 123 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.98139507 |
| 124 | mature B cell differentiation (GO:0002335) | 2.97374606 |
| 125 | alpha-beta T cell activation (GO:0046631) | 2.97266734 |
| 126 | positive regulation of T cell cytokine production (GO:0002726) | 2.97189913 |
| 127 | T cell proliferation (GO:0042098) | 2.96127641 |
| 128 | regulation of response to interferon-gamma (GO:0060330) | 2.95292652 |
| 129 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95180777 |
| 130 | T cell activation involved in immune response (GO:0002286) | 2.94133566 |
| 131 | defense response to protozoan (GO:0042832) | 2.93587808 |
| 132 | positive regulation of cell killing (GO:0031343) | 2.93434847 |
| 133 | mast cell activation (GO:0045576) | 2.93278039 |
| 134 | leukocyte degranulation (GO:0043299) | 2.93025643 |
| 135 | detection of external biotic stimulus (GO:0098581) | 2.93004398 |
| 136 | B cell mediated immunity (GO:0019724) | 2.92101771 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 2.91997564 |
| 138 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91382098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.11094551 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.95915363 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.38317640 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.57091330 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.46689655 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.84933472 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.83786291 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.51117728 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.38155331 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.38050704 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.24533994 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.21667415 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05773655 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 3.00811483 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.00324403 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98905867 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98447459 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83821627 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.70625602 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61496860 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55024995 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.51745605 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.49036668 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.44816708 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26436296 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20930604 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.06492732 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03925838 |
| 29 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96299789 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94562998 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93895163 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93496178 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92324503 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89984925 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89026747 |
| 36 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84737532 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84452670 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81924675 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77931566 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76678027 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.73002342 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63594630 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61176480 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.58243996 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55549653 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55191591 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54917906 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53942079 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47374914 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47004938 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44620631 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41156008 |
| 53 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38399559 |
| 54 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.34617336 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33892813 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31564459 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31270039 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30037231 |
| 59 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26123985 |
| 60 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23043416 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21903255 |
| 62 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21821610 |
| 63 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20732281 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19301970 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16138082 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14028258 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12228993 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11948386 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05404638 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05052713 |
| 71 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03155665 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02525020 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02473408 |
| 74 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00075017 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97985292 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96678066 |
| 77 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95243935 |
| 78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94544433 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91612946 |
| 80 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89849173 |
| 81 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88827116 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88124891 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88000693 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87328153 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86917049 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86221589 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86136290 |
| 88 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84928204 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83962520 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81157887 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80015825 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79385529 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77100143 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76774661 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75747298 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70954220 |
| 97 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70883724 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.70862689 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70257269 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68642306 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66704859 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.65705070 |
| 103 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63730082 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63580937 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.63311913 |
| 106 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63086527 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61145723 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.60751333 |
| 109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.60219818 |
| 110 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.60074220 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59929720 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58477525 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.57851178 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.56720089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.85444377 |
| 2 | MP0000685_abnormal_immune_system | 3.87895376 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.64618722 |
| 4 | MP0001790_abnormal_immune_system | 3.46006036 |
| 5 | MP0005387_immune_system_phenotype | 3.46006036 |
| 6 | * MP0005671_abnormal_response_to | 3.45262255 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.26926729 |
| 8 | MP0001800_abnormal_humoral_immune | 3.23447941 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.15375706 |
| 10 | MP0009785_altered_susceptibility_to | 3.11023304 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.09228758 |
| 12 | MP0003436_decreased_susceptibility_to | 3.07369763 |
| 13 | MP0003303_peritoneal_inflammation | 3.01599704 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.87383990 |
| 15 | MP0002723_abnormal_immune_serum | 2.82864162 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.70814951 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.69456352 |
| 18 | * MP0001819_abnormal_immune_cell | 2.69339757 |
| 19 | MP0005025_abnormal_response_to | 2.66969172 |
| 20 | MP0004510_myositis | 2.49961459 |
| 21 | MP0002398_abnormal_bone_marrow | 2.36711247 |
| 22 | MP0002419_abnormal_innate_immunity | 2.34832125 |
| 23 | MP0002006_tumorigenesis | 2.33123148 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.25966230 |
| 25 | * MP0000716_abnormal_immune_system | 2.20143373 |
| 26 | MP0002405_respiratory_system_inflammati | 2.18076181 |
| 27 | MP0001853_heart_inflammation | 2.10712985 |
| 28 | MP0001873_stomach_inflammation | 2.07627484 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.05058985 |
| 30 | MP0003724_increased_susceptibility_to | 2.00090005 |
| 31 | MP0005310_abnormal_salivary_gland | 1.99959870 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.98028804 |
| 33 | MP0001348_abnormal_lacrimal_gland | 1.93143689 |
| 34 | MP0006082_CNS_inflammation | 1.90698182 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.83316870 |
| 36 | * MP0002722_abnormal_immune_system | 1.80697946 |
| 37 | MP0004947_skin_inflammation | 1.80210274 |
| 38 | * MP0002429_abnormal_blood_cell | 1.75890917 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.75627909 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.68262339 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.67715894 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.67614375 |
| 43 | MP0003866_abnormal_defecation | 1.67450622 |
| 44 | MP0002009_preneoplasia | 1.48186377 |
| 45 | MP0002163_abnormal_gland_morphology | 1.47761697 |
| 46 | MP0003448_altered_tumor_morphology | 1.45936445 |
| 47 | MP0008057_abnormal_DNA_replication | 1.42687564 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.42383349 |
| 49 | MP0005451_abnormal_body_composition | 1.40476617 |
| 50 | MP0002933_joint_inflammation | 1.35924430 |
| 51 | MP0000858_altered_metastatic_potential | 1.32234360 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.31571736 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.31571736 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.31549770 |
| 55 | MP0008469_abnormal_protein_level | 1.26414316 |
| 56 | MP0000490_abnormal_crypts_of | 1.20904803 |
| 57 | MP0008260_abnormal_autophagy | 1.19008971 |
| 58 | MP0009764_decreased_sensitivity_to | 1.17459259 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.10303996 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.01010547 |
| 61 | MP0009278_abnormal_bone_marrow | 0.97389205 |
| 62 | MP0001881_abnormal_mammary_gland | 0.95680755 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.95184769 |
| 64 | MP0002254_reproductive_system_inflammat | 0.94570161 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.91828769 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 0.91419047 |
| 67 | MP0005174_abnormal_tail_pigmentation | 0.88295148 |
| 68 | MP0001851_eye_inflammation | 0.84085632 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.79469310 |
| 70 | * MP0002019_abnormal_tumor_incidence | 0.79314946 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.78613141 |
| 72 | MP0004883_abnormal_blood_vessel | 0.77217057 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.76351054 |
| 74 | MP0000569_abnormal_digit_pigmentation | 0.73520107 |
| 75 | MP0009763_increased_sensitivity_to | 0.72936082 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 0.71779287 |
| 77 | MP0003091_abnormal_cell_migration | 0.71298385 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.69096246 |
| 79 | MP0001663_abnormal_digestive_system | 0.66579177 |
| 80 | MP0000604_amyloidosis | 0.66123197 |
| 81 | MP0003828_pulmonary_edema | 0.63550322 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.63367273 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.61808380 |
| 84 | MP0000249_abnormal_blood_vessel | 0.61079508 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.60811196 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.60321242 |
| 87 | MP0005164_abnormal_response_to | 0.57442044 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.57191364 |
| 89 | MP0000627_abnormal_mammary_gland | 0.57017768 |
| 90 | MP0010307_abnormal_tumor_latency | 0.57007195 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.56253549 |
| 92 | MP0003045_fibrosis | 0.56076915 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.55865377 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.53607492 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.53205879 |
| 96 | MP0001919_abnormal_reproductive_system | 0.53083966 |
| 97 | MP0005390_skeleton_phenotype | 0.52797216 |
| 98 | MP0003075_altered_response_to | 0.52627079 |
| 99 | MP0000343_altered_response_to | 0.52132434 |
| 100 | MP0004381_abnormal_hair_follicle | 0.50405650 |
| 101 | MP0001243_abnormal_dermal_layer | 0.49593238 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.48840723 |
| 103 | MP0003795_abnormal_bone_structure | 0.48591207 |
| 104 | MP0000609_abnormal_liver_physiology | 0.48453296 |
| 105 | MP0002132_abnormal_respiratory_system | 0.47467030 |
| 106 | MP0000371_diluted_coat_color | 0.46638925 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.44312023 |
| 108 | MP0005166_decreased_susceptibility_to | 0.43567034 |
| 109 | MP0000613_abnormal_salivary_gland | 0.43542880 |
| 110 | MP0008007_abnormal_cellular_replicative | 0.43387123 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.43092271 |
| 112 | MP0003252_abnormal_bile_duct | 0.42405038 |
| 113 | MP0003690_abnormal_glial_cell | 0.42160354 |
| 114 | MP0004130_abnormal_muscle_cell | 0.41955440 |
| 115 | MP0008004_abnormal_stomach_pH | 0.41326941 |
| 116 | MP0008873_increased_physiological_sensi | 0.41074603 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.40873667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.39495899 |
| 2 | Myositis (HP:0100614) | 4.98419787 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.92425360 |
| 4 | T lymphocytopenia (HP:0005403) | 4.81099644 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78757011 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.77540424 |
| 7 | Optic neuritis (HP:0100653) | 4.65135888 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.65135888 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.59402110 |
| 10 | Recurrent viral infections (HP:0004429) | 4.54030567 |
| 11 | Chronic otitis media (HP:0000389) | 4.39802955 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.39543343 |
| 13 | Orchitis (HP:0100796) | 4.33892822 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.32971827 |
| 15 | Stomatitis (HP:0010280) | 4.03721902 |
| 16 | Abnormality of T cells (HP:0002843) | 3.97650715 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.90198902 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.90198902 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89054610 |
| 20 | Vasculitis (HP:0002633) | 3.87797579 |
| 21 | Meningitis (HP:0001287) | 3.79253209 |
| 22 | IgM deficiency (HP:0002850) | 3.78922916 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.76966892 |
| 24 | Nasal polyposis (HP:0100582) | 3.75674651 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.74973951 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.72139106 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.54224583 |
| 28 | Increased IgM level (HP:0003496) | 3.52883668 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.51125301 |
| 30 | Recurrent skin infections (HP:0001581) | 3.47361284 |
| 31 | Arterial thrombosis (HP:0004420) | 3.41793837 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.35979149 |
| 33 | Obstructive lung disease (HP:0006536) | 3.34302288 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34302288 |
| 35 | Thrombocytosis (HP:0001894) | 3.31841460 |
| 36 | Inflammation of the large intestine (HP:0002037) | 3.28971274 |
| 37 | IgG deficiency (HP:0004315) | 3.28754759 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.28137040 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 3.23793228 |
| 40 | Cellulitis (HP:0100658) | 3.22226341 |
| 41 | Hemoptysis (HP:0002105) | 3.20040685 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.18478017 |
| 43 | Thyroiditis (HP:0100646) | 3.18114991 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 3.17214755 |
| 45 | Combined immunodeficiency (HP:0005387) | 3.15910581 |
| 46 | Abnormality of macrophages (HP:0004311) | 3.13397203 |
| 47 | Abnormality of B cell number (HP:0010975) | 3.12648205 |
| 48 | B lymphocytopenia (HP:0010976) | 3.12648205 |
| 49 | Eosinophilia (HP:0001880) | 3.11639236 |
| 50 | Leukocytosis (HP:0001974) | 3.10569885 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 3.09980939 |
| 52 | Abnormality of the fingertips (HP:0001211) | 3.09645368 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08312081 |
| 54 | Abnormality of eosinophils (HP:0001879) | 3.05463948 |
| 55 | Spontaneous hematomas (HP:0007420) | 3.02805219 |
| 56 | Encephalitis (HP:0002383) | 3.01687170 |
| 57 | Lymphopenia (HP:0001888) | 2.98062556 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97878363 |
| 59 | Chronic diarrhea (HP:0002028) | 2.94990375 |
| 60 | Increased IgE level (HP:0003212) | 2.93273294 |
| 61 | Chest pain (HP:0100749) | 2.84965897 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.83573098 |
| 63 | Colitis (HP:0002583) | 2.82760398 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.82461103 |
| 65 | Pustule (HP:0200039) | 2.82271497 |
| 66 | Granulocytopenia (HP:0001913) | 2.80468516 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.75913353 |
| 68 | IgA deficiency (HP:0002720) | 2.71735755 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.71104131 |
| 70 | Recurrent sinusitis (HP:0011108) | 2.68909010 |
| 71 | Chronic sinusitis (HP:0011109) | 2.68587783 |
| 72 | Gingival bleeding (HP:0000225) | 2.64703638 |
| 73 | Fatigue (HP:0012378) | 2.60504483 |
| 74 | Verrucae (HP:0200043) | 2.60477324 |
| 75 | Papilloma (HP:0012740) | 2.60477324 |
| 76 | Gingivitis (HP:0000230) | 2.55002326 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.54701142 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.54034368 |
| 79 | Periodontitis (HP:0000704) | 2.53036666 |
| 80 | Joint swelling (HP:0001386) | 2.48395636 |
| 81 | Bronchitis (HP:0012387) | 2.46077412 |
| 82 | Pulmonary embolism (HP:0002204) | 2.40215957 |
| 83 | Stomach cancer (HP:0012126) | 2.39276191 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.37467390 |
| 85 | Keratitis (HP:0000491) | 2.34463387 |
| 86 | Glomerulopathy (HP:0100820) | 2.34121619 |
| 87 | Osteomyelitis (HP:0002754) | 2.34081444 |
| 88 | Gangrene (HP:0100758) | 2.31343796 |
| 89 | Epistaxis (HP:0000421) | 2.28076661 |
| 90 | Recurrent pneumonia (HP:0006532) | 2.27513485 |
| 91 | Amaurosis fugax (HP:0100576) | 2.25152286 |
| 92 | Skin rash (HP:0000988) | 2.22869572 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.22648541 |
| 94 | Myocardial infarction (HP:0001658) | 2.20327010 |
| 95 | Emphysema (HP:0002097) | 2.19009742 |
| 96 | Hypochromic anemia (HP:0001931) | 2.18377978 |
| 97 | Lymphoma (HP:0002665) | 2.18021448 |
| 98 | Skin ulcer (HP:0200042) | 2.15595974 |
| 99 | Petechiae (HP:0000967) | 2.11850495 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11845261 |
| 101 | Sepsis (HP:0100806) | 2.09974663 |
| 102 | Alveolar cell carcinoma (HP:0006519) | 2.09736467 |
| 103 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08704589 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 2.08130594 |
| 105 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.05179481 |
| 106 | Restrictive lung disease (HP:0002091) | 2.05125878 |
| 107 | Abnormality of the endocardium (HP:0004306) | 2.04281683 |
| 108 | Acute hepatic failure (HP:0006554) | 2.04250276 |
| 109 | Polyneuropathy (HP:0001271) | 2.03120798 |
| 110 | Urticaria (HP:0001025) | 2.02860920 |
| 111 | Anorexia (HP:0002039) | 2.02466796 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.02108373 |
| 113 | Arthralgia (HP:0002829) | 2.01903638 |
| 114 | Prostate neoplasm (HP:0100787) | 1.98590993 |
| 115 | Slow saccadic eye movements (HP:0000514) | 1.93065565 |
| 116 | Vertigo (HP:0002321) | 1.92516923 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.91565414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.67058252 |
| 2 | TXK | 4.49260064 |
| 3 | MAP3K14 | 4.08031836 |
| 4 | JAK3 | 3.24971811 |
| 5 | TYK2 | 3.05760851 |
| 6 | TBK1 | 2.79902660 |
| 7 | IKBKE | 2.74157017 |
| 8 | IKBKB | 2.68407133 |
| 9 | IRAK4 | 2.37150377 |
| 10 | BLK | 2.34818254 |
| 11 | ZAP70 | 2.33821705 |
| 12 | JAK1 | 2.27372263 |
| 13 | PRPF4B | 2.21669534 |
| 14 | ITK | 2.07501606 |
| 15 | FGFR4 | 2.03990572 |
| 16 | MAP3K13 | 2.00840458 |
| 17 | CHUK | 1.94206914 |
| 18 | STK10 | 1.89184729 |
| 19 | GRK6 | 1.88204951 |
| 20 | IRAK3 | 1.85170334 |
| 21 | TEC | 1.78444032 |
| 22 | NLK | 1.75363120 |
| 23 | BTK | 1.71444000 |
| 24 | FGFR3 | 1.70685965 |
| 25 | MST4 | 1.69390402 |
| 26 | SYK | 1.65175365 |
| 27 | RIPK4 | 1.61870475 |
| 28 | PIM1 | 1.56284850 |
| 29 | LCK | 1.52598111 |
| 30 | EPHA3 | 1.48145901 |
| 31 | CSK | 1.45331672 |
| 32 | EPHB1 | 1.44442022 |
| 33 | MAP3K10 | 1.44385426 |
| 34 | KIT | 1.40781184 |
| 35 | HCK | 1.38094773 |
| 36 | NEK9 | 1.32199066 |
| 37 | CAMKK2 | 1.27767414 |
| 38 | CSF1R | 1.24698819 |
| 39 | JAK2 | 1.21112621 |
| 40 | PIM2 | 1.19838954 |
| 41 | TAOK3 | 1.19233231 |
| 42 | LRRK2 | 1.16642266 |
| 43 | PRKCQ | 1.00784704 |
| 44 | NME2 | 0.97084636 |
| 45 | IRAK1 | 0.96155040 |
| 46 | SIK3 | 0.95524323 |
| 47 | PIK3CG | 0.92895006 |
| 48 | LYN | 0.92844574 |
| 49 | MAP2K3 | 0.88129069 |
| 50 | RPS6KA4 | 0.87126759 |
| 51 | TGFBR2 | 0.86735617 |
| 52 | MARK3 | 0.86191870 |
| 53 | TRIB3 | 0.85785709 |
| 54 | MAP3K1 | 0.85751671 |
| 55 | FLT3 | 0.83911584 |
| 56 | STK4 | 0.83885154 |
| 57 | CAMKK1 | 0.83364094 |
| 58 | PKN2 | 0.80848121 |
| 59 | ERN1 | 0.77226231 |
| 60 | SIK2 | 0.77136615 |
| 61 | MAPK7 | 0.76779600 |
| 62 | PASK | 0.75357634 |
| 63 | STK24 | 0.75318482 |
| 64 | FES | 0.74541336 |
| 65 | CLK1 | 0.74127611 |
| 66 | MAP3K3 | 0.69355076 |
| 67 | EEF2K | 0.67424224 |
| 68 | MAPK11 | 0.63672938 |
| 69 | MAP2K2 | 0.63389949 |
| 70 | MAPK12 | 0.63318645 |
| 71 | CDK12 | 0.56076124 |
| 72 | CDK9 | 0.52941033 |
| 73 | HIPK2 | 0.49655335 |
| 74 | NUAK1 | 0.49567539 |
| 75 | MAPKAPK2 | 0.47782167 |
| 76 | BMPR2 | 0.47452823 |
| 77 | TAOK2 | 0.46903966 |
| 78 | GRK7 | 0.46535532 |
| 79 | PTK6 | 0.45867526 |
| 80 | TNK2 | 0.45585587 |
| 81 | ABL1 | 0.43866286 |
| 82 | RPS6KA5 | 0.43454142 |
| 83 | KDR | 0.42246603 |
| 84 | CDK6 | 0.40098919 |
| 85 | PDPK1 | 0.39555461 |
| 86 | TAOK1 | 0.39296948 |
| 87 | CDK4 | 0.39200461 |
| 88 | NEK6 | 0.38806369 |
| 89 | EIF2AK2 | 0.37442457 |
| 90 | PDK1 | 0.37153029 |
| 91 | PDGFRB | 0.35508210 |
| 92 | BMX | 0.34983115 |
| 93 | YES1 | 0.34076005 |
| 94 | PRKCD | 0.33926252 |
| 95 | IRAK2 | 0.33813534 |
| 96 | KSR2 | 0.32305528 |
| 97 | TESK2 | 0.31268930 |
| 98 | ALK | 0.30780858 |
| 99 | BCKDK | 0.30753643 |
| 100 | TRPM7 | 0.30709685 |
| 101 | CDK19 | 0.30107350 |
| 102 | MAP3K8 | 0.29972433 |
| 103 | MAP3K5 | 0.29602626 |
| 104 | DYRK1B | 0.28721409 |
| 105 | RPS6KA6 | 0.28673046 |
| 106 | PRKCH | 0.28095822 |
| 107 | MARK2 | 0.27791107 |
| 108 | SGK2 | 0.27515594 |
| 109 | TYRO3 | 0.27156421 |
| 110 | EGFR | 0.27135315 |
| 111 | SGK3 | 0.26845196 |
| 112 | RPS6KA1 | 0.26718655 |
| 113 | MAP3K7 | 0.26256717 |
| 114 | MELK | 0.25778621 |
| 115 | FGR | 0.25617495 |
| 116 | PKN1 | 0.23844350 |
| 117 | FYN | 0.23737302 |
| 118 | MAP3K11 | 0.23398939 |
| 119 | TLK1 | 0.22908822 |
| 120 | PRKD2 | 0.22890891 |
| 121 | MAPK4 | 0.22549568 |
| 122 | SIK1 | 0.22520412 |
| 123 | RPS6KC1 | 0.22078477 |
| 124 | RET | 0.22043875 |
| 125 | INSR | 0.21851226 |
| 126 | IGF1R | 0.21737280 |
| 127 | MATK | 0.21553716 |
| 128 | MAP2K6 | 0.21073208 |
| 129 | MAPK3 | 0.19635864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.86438761 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.35581366 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.25827686 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10240319 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.87893035 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77327430 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.76004430 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.65747621 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.44569077 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43702847 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30165492 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24656450 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12695166 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07455234 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.03522549 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99629853 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93153728 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92964793 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88040355 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.82384466 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80773731 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73886055 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70964507 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64434662 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64333823 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61769870 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.58804386 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.48163162 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47833089 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.43345270 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.42225446 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41140262 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.41136087 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.38454132 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36887341 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.35960181 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33346591 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.30190857 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.22491957 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21710001 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.21282706 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16879383 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11055685 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04999653 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00729309 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 0.96995295 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.94571660 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94048166 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93254349 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93100029 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.91408167 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86847210 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84221539 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82733705 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82406796 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75817887 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73433211 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70661166 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68971026 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66950383 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63200948 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58514828 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56765350 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55538919 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50434187 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49835390 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46746196 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45982933 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45293230 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.43274230 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40956569 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.37097726 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37066798 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.35883632 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35797689 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35171606 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34398789 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34264773 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31892679 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.31872158 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31826922 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.31755725 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31400361 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31120624 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30651310 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.28967787 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28530073 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.27258499 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26014120 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25824578 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25733374 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24929683 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.23773078 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23337045 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22067804 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21955825 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21018365 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20470791 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20393569 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19426434 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18871854 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18296465 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17635723 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17094476 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15470404 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15081373 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14640689 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14075611 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13873494 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.12596613 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12151740 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10544778 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08378931 |

